Belinario, Allan E.

HRN: 13-84-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/03/2026
05/05/2026
IV
2.25g
Q8
Complicated Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: Compliant To Guidelines